MedTech Dive November 17, 2023
Kazemi hopes anyone with diabetes will be able to access the technology, even people who don’t take insulin.
The Centers for Medicare and Medicaid Services in April expanded Medicare coverage of continuous glucose monitors (CGMs) for people with Type 2 diabetes who only take basal insulin or who have a history of hypoglycemia.
Abbott, one of the leading CGM makers in the diabetes tech market, estimated that the coverage change would open access for 2 million people.
Mahmood Kazemi, chief medical officer of Abbott Diabetes Care, also hopes to broaden access for people covered by Medicaid and more people who don’t take insulin as part of their treatment. Kazemi spoke with MedTech Dive about recent studies and other efforts by...
Today's Sponsors
Today's Sponsor